Ligand Pharmaceuticals LGND Free cash flow yield
Free cash flow yield at other companies
Other financials
Where this comes from
Calculated from Ligand Pharmaceuticals’s reported figures.
Based on trailing twelve months.
The official record: Ligand Pharmaceuticals’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →
Ask your AI about Ligand Pharmaceuticals's free cash flow yield.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Ligand Pharmaceuticals's free cash flow yield?
- Ligand Pharmaceuticals (LGND) reported free cash flow yield of 3.1% in Q1 2026.
- How has Ligand Pharmaceuticals's free cash flow yield changed year-over-year?
- Ligand Pharmaceuticals's free cash flow yield increased by 22.8% year-over-year, from 2.5% to 3.1%.
- What is the long-term trend for Ligand Pharmaceuticals's free cash flow yield?
- Over 5 years (2020 to 2025), Ligand Pharmaceuticals's free cash flow yield has grown at a -15.7% compound annual growth rate (CAGR), from 3.1% to 1.3%.
- What does free cash flow yield mean?
- Trailing-twelve-month free cash flow divided by market capitalization at the quarter end. The cash return the business generates relative to its market price.